Gonococcal seminal vesiculitis

Summary

Gonococcal seminal vesiculitis (MONDO:0001027) is a disease. A subtype of gonorrhea — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gonococcal seminal vesiculitis
Mondo ID	MONDO:0001027
DOID	DOID:10400
ICD-11	1226540022
SNOMED CT	301990003
UMLS	C0578661
MedGen	662073
Is cancer (heuristic)	no

Also known as: gonococcal seminal vesiculitis (acute) · gonorrhoea of seminal vesicle · seminal vesicle gonorrhea · seminal vesicle gonorrhoea

Disease family

This is a subtype of gonorrhea. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › gonorrhea › gonococcal seminal vesiculitis

Related subtypes (11): gonococcal spondylitis, gonococcal bursitis, gonococcal endophthalmia, gonococcal conjunctivitis, gonococcal urethritis, gonococcal cervicitis, gonococcal epididymo-orchitis, gonococcal salpingitis, gonococcal cystitis, gonococcal prostatitis, gonococcal infection of joint

Subtypes (2): seminal vesicle acute gonorrhea, seminal vesicle chronic gonorrhea

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.